RBC Capital analyst Mark Dwelle raised the firm’s price target on CNO Financial (CNO) to $40 from $38 and keeps an Outperform rating on the shares. The company reported another quarter of upside, with the Health segment seen as the key driver in the quarter, the analyst tells investors in a research note. Net investment income also remains a tailwind as new money yields are higher, RBC added.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.